-
1 Comment
CanadaBis Capital Inc is currently in a long term downtrend where the price is trading 5.2% below its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.6.
CanadaBis Capital Inc's total revenue rose by 419.2% to $1M since the same quarter in the previous year.
Its net income has increased by 41.5% to $-829K since the same quarter in the previous year.
Finally, its free cash flow grew by 126.7% to $130K since the same quarter in the previous year.
Based on the above factors, CanadaBis Capital Inc gets an overall score of 4/5.
Exchange | V |
---|---|
CurrencyCode | CAD |
ISIN | CA13530Q1046 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Market Cap | 12M |
---|---|
PE Ratio | None |
Beta | 0.45 |
Target Price | None |
Dividend Yield | None |
CanadaBis Capital Inc. engages in the production and sale of recreational cannabis and cannabis extracts in Canada. It operates through three segments: cultivation and wholesale, retail, and extract. The company cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. It is also involved in the sale of cannabis and cannabis related products to end consumers on premise owned and operated by the company; and wholesale extract products to distributors and licensed cannabis producers. CanadaBis Capital Inc. was formerly known as 1926360 Alberta Ltd. and changed its name to CanadaBis Capital Inc. in April 2019. The company was incorporated 2016 and is based in Red Deer County, Canada.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for CANB.V using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025